Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.

ABSTRACT:

Background

Sweden revised their cervical cancer screening program in 2017 to include cytology-based screening for women aged 23-29 years and primary human papillomavirus (HPV) testing for women aged 30-64 years; however, alternative strategies may be preferred. To inform cervical cancer prevention policies for unvaccinated women, we evaluated the cost-effectiveness of alternative screening strategies, including the current Swedish guidelines.

Methods

We adapted a mathematical simulation model of HPV and cervical cancer to the Swedish context using primary epidemiologic data. We compared the cost-effectiveness of alternative screening strategies that varied by the age to start screening, the age to switch from cytology to HPV testing, HPV strategies not preceded by cytology,

SUBMITTER: Fogelberg S 

PROVIDER: S-EPMC7526933 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature